New study aims to Fine-Tune blood thinner dosing for heart patients before surgery

NCT ID NCT07225842

First seen Nov 10, 2025 · Last updated May 21, 2026 · Updated 24 times

Summary

This study looks at whether adjusting the dose of the blood thinner cangrelor based on individual test results can better control clotting risk in people with coronary artery disease who need to pause their regular medication before surgery. About 50 adults will receive either a standard or tailored dose. The goal is to find the right balance to prevent both clots and bleeding.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERIAL DISEASE (CAD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Florida Jacksonville

    RECRUITING

    Jacksonville, Florida, 32209, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.